Asia-Pacific Journal of Clinical Oncology

Papers
(The TQCC of Asia-Pacific Journal of Clinical Oncology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
2021 Hunter Cancer Research Symposium50
27
24
Real‐world effectiveness of regorafenib in the treatment of patients with metastatic colorectal cancer: A retrospective, observational study22
Association between financial toxicity and health‐related quality of life in cancer survivors: A systematic review19
Prevention and management of acneiform rash associated with EGFR inhibitor therapy: A systematic review and meta‐analysis17
The impact of coronavirus disease 2019 on genitourinary and prostate cancer care and clinical trials: A qualitative exploration of the Australian and New Zealand experience17
Phase 1 trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study)14
Incidence and risk factors for neoplasia in inflammatory bowel disease13
T‐cell lymphoma patient harboring BCL11B mutations had favorable overall survival13
Optimizing Digital Mental Health Interventions for Breast Cancer Survivors: Insights and Future Directions12
12
Systematic Literature Review on the Burden of Human Papillomavirus Infection and Related Diseases in India11
Advancing ovarian cancer diagnosis: harnessing artificial intelligence and novel biomarker strategies11
Organising Committee11
“Artificial Intelligence in NAFLD Diagnosis: A New Frontier in Managing Metastatic Prostate Cancer Risk”11
Issue Information11
Issue Information10
ANZUP Fellowships and Awards10
10
List of Poster Abstracts10
Glucose to lymphocyte ratio predicts prognoses in patients with colorectal cancer10
ANZUP MDT Masterclass Convenor Welcome10
Telehealth adoption in cancer clinical trials: An Australian perspective9
Participation in oral health screening among cancer survivors8
PD‐L1 heterogeneity in patients with non–small cell lung cancer8
Pictorial essay on MRI local staging of rectal carcinoma: An easy approach8
Impact of age on outcomes in young women with breast cancer8
Safety and efficacy of high‐dose cytarabine MEAM therapy and other treatments for auto‐peripheral blood stem cell transplantation: A retrospective comparative study8
A feasibility study of modified docetaxel, cisplatin, and capecitabine for advanced gastric cancer followed by gastrectomy8
Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma: Does the sequence matter?8
Incidence, clinicopathological characteristics, and therapeutic strategy for gastric cancer patients with metastasis to the central nervous system8
Correlation of 18‐fluorodeoxyglucose uptake values on PET–CT scan with histological prognostic markers in breast cancer8
TNM classification of malignant tumors: Eighth edition for retroperitoneal liposarcoma. Ways to improve7
Berberine and Lung Cancer: From Pure Form to Its Nanoformulations7
Incidence, mortality, survival, and disease burden of breast cancer in China compared to other developed countries7
Functional results and feasibility of a teleprehabilitation program in patients who are candidates for elective colorectal cancer surgery during the COVID‐19 pandemic7
Breast Cancer Awareness and the Practice of Self Breast Examination Among Undergraduate Students in Karachi, Pakistan7
Effectiveness and Toxicity of Anticancer Agents in Older Australian Patients: A Retrospective Analysis7
Treatment patterns and long‐term survival outcomes for patients with stage III non‐small cell lung cancer: A retrospective study7
Multi‐omic analysis of dysregulated pathways in triple negative breast cancer7
Real‐World Experience Using Brigimadlin (MDM2 Inhibitor) in an Australian Sarcoma Specialist Center Compared to Pivotal Clinical Trial Results7
Poster Abstracts6
Clinical and molecular profile of young adults with early‐onset colorectal cancer: Experience from four Australian tertiary centers6
International Speakers6
Change in the neutrophil‐lymphocyte ratio may predict early recurrence in operated bladder cancer6
A message from HCRA Directors and the Symposium Scientific Committee6
Highlighted Lectures and Awards 20216
Asia‐Pacific Leukemia Consortium: An innovative and collaborative initiative to improve care of leukemia and related diseases in the Asia‐Pacific region6
Author Listing6
Issue Information6
6
Demographic and clinical profile of 1106 adult soft tissue sarcoma patients: A single institutional prospective database experience from India6
Author Index6
National Speakers6
What affects the public healthcare costs of breast cancer in New Zealand?5
Risk factors, histopathological landscape, biomarkers, treatment patterns and survival of early‐onset colorectal cancer: A narrative review5
Current status of total neoadjuvant therapy for locally advanced rectal cancer5
5
Issue Information5
The management of HER2‐positive early breast cancer: Current and future therapies5
A prospective observational cohort study examining the development of head and neck lymphedema from the time of diagnosis5
Real‐world tolerance and outcomes of oxaliplatin‐based adjuvant chemotherapy for stage III colon cancer—Does dose intensity matter?5
Panel Speakers5
Abstracts5
Cancer Clinical Trial Participation Amongst Culturally and Linguistically Diverse Patients in Australia5
The association of socioeconomic deprivation with access and survival after hematopoietic stem cell transplantation in New Zealand5
Image‐guided percutaneous needle biopsy for the diagnosis of cancer of unknown primary5
Re‐re‐biopsy? How much tumor is enough in the era of precision oncology?5
Convenors' Welcome5
E‐POSTER LISTING5
Poster Abstracts5
Prognostic markers including immune and inflammatory factors predict outcomes in patients receiving postoperative radiation therapy for cholangiocarcinoma5
Opinions and strategies of Australian health professionals on tackling cancer‐related financial toxicity: A nationwide survey5
Trends in phase 1 oncology clinical trials across Australia; Analysis of ClinicalTrials.gov 2012–20224
Abstracts for Poster Presentations (with mini‐oral)4
Cancer survivors’ exercise beliefs, knowledge, and behaviors: An Australian National Survey4
Issue Information4
Evaluation of the anticarcinogenic effects of Rutin on brain tissue in mice with Ehrlich ascites carcinoma by micro‐computed tomography and histological methods4
Poster Abstracts4
Prognostic Value of CD133 and SOX2 Expression After Neoadjuvant Chemotherapy in Patients With Locally Advanced Gastric Cancer4
Exploring the molecular mechanisms network of breast cancer by multi‐omics analysis4
Prognostic value of human epidermal growth factor receptor 2 status and systemic therapy in breast cancer with brain metastases treated with radiotherapy4
Teletrials, the new norm? Expert recommendations for teletrials into the future: Findings from the Clinical Oncology Society of Australia Clinical Trial Research Professionals Group Workshop4
Impact of neoadjuvant systemic chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal adenocarcinoma4
CD151 and prostate cancer progression: A review of current literature4
List of Poster Abstracts4
Risk classification system using the detailed positive surgical margin status for predicting biochemical recurrence after robot‐assisted radical prostatectomy4
A multi‐institutional retrospective study of open versus laparoscopic nephroureterectomy focused on the intravesical recurrence4
A multidimensional assessment of payback: Evaluating the impact of Breast Cancer Trials4
Implementing a group‐based online mental well‐being program for women living with and beyond breast cancer – A mixed methods study4
The clinical utility of autologous tumor lysate‐loaded dendritic cell vaccination for patients with glioma: A systematic review and meta‐analysis4
COSA President's Welcome4
Molecular characteristics of young‐onset colorectal cancer in Vietnamese patients4
E74‐like factor 4 promotes the proliferation, invasion, and migration of colorectal cancer cells via long non‐coding RNA integrin subunit beta 8 antisense RNA 1‐mediated histone H3 lysine 27 trimethyl3
A national survey of oncology physiotherapy services for cancer survivors in Australia3
A risk factor analysis for local recurrence of bone and soft tissue sarcoma treated with carbon ion radiotherapy: A retrospective cohort study at a single institution3
Author List3
Selective internal radiation therapy with yttrium‐90 resin microspheres followed by anatomical hepatectomy: A potential curative strategy in advanced hepatocellular carcinoma3
The prognostic significance of immune checkpoint receptor expression in patients with lymphoma: Association with disease status and clinical outcomes3
3
Centralization and prospective audit of cystectomy are necessary: a commentary on the case for centralization, supported by a contemporary series utilizing the ANZUP cystectomy database3
ANZUP Chair Welcome3
Young Oncologist Oral Presentation Abstracts3
3
Comparison of direct medical care costs between patients receiving care in a designated palliative care unit and the usual care units3
Upregulation of O‐GlcNAc transferase is involved in the pathogenesis of acute myeloid leukemia3
Clinical and genetic characteristics of early‐stage multiple primary and independent primary lung adenocarcinoma patients3
Association of chemotherapy dose intensity and age with outcomes in patients with Ewing's family sarcoma3
A novel exosome‐related prognostic risk model for thyroid cancer3
Neo‐adjuvant FOLFIRINOX in borderline resectable and locally advanced pancreatic adenocarcinoma3
Oral presentation abstracts3
Impact of incorporating Magnetic Resonance Imaging in FIGO Staging of Primary Carcinoma Cervix: Experience from a tertiary cancer center3
Overdiagnosis and overtreatment of ground‐glass nodule‐like lung cancer3
Trainee Oral Presentation Abstracts3
Highlighted Lectures and Awards 20223
3
A prospective study of diagnostic accuracy of multidisciplinary team and radiology reporting of preoperative colorectal cancer local staging3
Prevalence and risk factors of chemotherapy‐induced oral mucositis among adult cancer patients at the cancer unit of Mbarara Regional Referral Hospital3
Poster Abstracts3
Real‐world multicenter study of the safety and efficacy of netupitant plus palonosetron fixed‐dose combination to prevent chemotherapy‐induced nausea and vomiting among Malaysian patients receiving mo3
Cost‐effectiveness analysis of human papillomavirus vaccines for the prevention of cervical cancer in India3
3
The benefits of an offline to online cognitive behavioral stress management regarding anxiety, depression, spiritual well‐being, and quality of life in postoperative intrahepatic cholangiocarcinoma pa3
3
Maintenance chemotherapy in advanced and metastatic pancreatic cancer, a narrative review and case series3
Poster Listing3
Issue Information3
Author Index3
AUTHOR INDEX3
3
Perceived importance of emotional support provided by health care professionals and social networks: Should we broaden our focus for the delivery of supportive care?3
Oncological outcomes for encapsulated papillary carcinoma of the breast: Multicentric study of Turkish Society for Radiation Oncology breast cancer study group (TROD 06–014 study)2
Efficacy and adverse events of immune checkpoint inhibitors in esophageal cancer patients: Challenges and perspectives for immunotherapy2
Early phase oncology clinical trials in Malaysia: current status and future perspectives2
2
Clinical Impact of Upfront Dose Reduction of the First Cycle of First‐Line Treatments on Safety and Survival in Elderly Patients With Non‐Small Cell Lung Cancer2
Clinical breast examination: A screening tool for lower‐ and middle‐income countries2
The burden of symptoms and quality of life of filipino patients with myeloproliferative neoplasm: A multicenter cross‐sectional survey2
Response to COVID‐19 vaccination in patients on cancer therapy: Analysis in a SARS‐CoV‐2‐naïve population2
Comprehensive analysis of the prognostic role of laboratory indices in advanced lung cancer patients2
BRCA Mutation Testing in Men With Metastatic Castration‐Resistant Prostate Cancer: Practical Guidance for Australian Clinical Practice2
Image‐guided thermal ablation for patients with epidermal growth factor receptor‐mutant nonsmall cell lung cancer2
Keynote Speakers2
Response from Batumalai V et al.2
Comparison of antibody response to coronavirus disease 2019 vaccination between patients with solid or hematologic cancer patients undergoing chemotherapy2
2
Exercise capacity prior to major cancer surgery: A cross‐sectional observational study of the validity of the 6‐minute walk and 30‐second sit‐to‐stand tests2
Patterns of curative treatment for non‐small cell lung cancer in New South Wales, Australia2
ASM Convening Committee2
Long‐term Longitudinal Observation of Lenvatinib‐associated Adverse Events in Patients With Unresectable Radioiodine‐refractory Differentiated Thyroid Cancer2
Consumers’ experiences, preferences, and perceptions of effectiveness in using telehealth for cancer care in Australia2
Recommended testing algorithms for NTRK gene fusions in pediatric and selected adult cancers: Consensus of a Singapore Task Force2
Efficacy evaluation of different measurement methods for target lesions after neoadjuvant chemotherapy and radical radiotherapy in locally advanced hypopharyngeal carcinoma2
ANZUP Scientific Program and Pre‐Conference Meetings2
Early Lung Cancer Patient Journey in Singapore: Challenges and Recommendations2
3D‐T2W‐TSE radiotherapy treatment planning MRI using compressed sensing acceleration for prostate cancer: Image quality and delineation value2
Recommendations for the treatment and management of adult B‐Cell acute lymphoblastic leukemia in Asia‐Pacific: Outcomes from a pilot initiative2
Clinical evidence and insights supporting the use of avelumab first‐line maintenance treatment in patients with advanced urothelial carcinoma in the Asia‐Pacific region2
Outcomes and prognostic predictors of Lu‐177 PSMA radioligand therapy in metastatic castration‐resistant prostate cancer (Asian Population Study)2
Current status and temporal trend of disease burden of thyroid cancer in China from 1990 to 20192
AUTHOR INDEX2
Breast cancer characteristics and pathological prognostic determinants in indigenous Australians: Retrospective cohort study in the Northern Territory2
Acknowledgements2
2
Prospective, open‐label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE study2
Real‐world outcomes for patients with pleural mesothelioma: A multisite retrospective cohort study2
2
Preoperative docetaxel, cisplatin, and fluorouracil treatment with pegfilgrastim on day 7 for patients with esophageal cancer: A phase II study2
Clinical features of gestational choriocarcinoma: A retrospective bicentric study2
Plenary speakers2
Quality Survivorship Care for People Affected by Advanced or Metastatic Cancer: A Clinical Oncology Society of Australia Endorsement of the Joint Multinational Association of Supportive Care in Cancer2
2
Sponsor acknowledgments2
Anaplastic thyroid cancer: A review of recent evidence and summary of an Australian institutional protocol2
eviQ Cancer Treatments Online: Providing evidence‐based information to improve cancer patient outcomes2
Highlighted Lectures and Awards 20242
Thoracic Cancer Exercise Services in Australia: A Point‐Prevalence Survey2
The Significance of Circulating Basophils as Predictors of Tumor Aggressiveness in Clear‐Cell Renal Cell Carcinoma2
Non‐alcoholic fatty liver disease increases the risk of biochemical recurrence in high‐grade metastatic prostate cancer patients2
Lag time to diagnosis as a predictor of mortality in children with extraocular retinoblastoma: Experience from a developing country2
Program in Detail2
The influence of transarterial chemoembolization on serum levels of soluble programed cell death ligand‐1 in advanced hepatocellular carcinoma patients2
Presenters and Chairs2
Sponsor Acknowledgements2
Metastatic Lobular Breast Cancer: Outcomes of Patients Treated at a Single Tertiary Institution2
Inflammation‐Based Prognostication in Extensive‐Stage Small Cell Lung Cancer in the First‐Line Setting: The Advanced Lung Inflammation Index and the Others2
Change in the Neutrophil–Lymphocyte Ratio and Recurrence in Operated Bladder Cancer2
Clinical Oncology Society of Australia Position Statement: 2022 update to the safe handling of monoclonal antibodies in healthcare settings2
0.080986022949219